Neuro-ophthalmic Manifestations of Checkpoint Inhibitors

Update item information
Identifier 20200310_nanos_posters_247
Title Neuro-ophthalmic Manifestations of Checkpoint Inhibitors
Creator Marez Megalla, Anita Kohli, Adeniyi Fisayo
Subject Chemotherapy and Radiation Injury, Neuro-ophth & Systemic Disease (eg. MS, MG, Thyroid)
Description Checkpoint inhibitors, such as ipilimumab, nivolimumab, and pembrolizumab, have been reported to cause ophthalmic adverse events. While myasthenia gravis induced by these medications has been previously documented, other neuro-ophthalmic manifestations have been rarely reported. This study aims to identify those rarer manifestations.
Relation is Part of NANOS Annual Meeting 2020: Poster Session II: Scientific Advancements
Contributor Primary Marez Megalla
Contributor Secondary Anita Kohli, Adeniyi Fisayo
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2020-03
Format application/pdf
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL
Language eng
ARK ark:/87278/s6ns64gj
Setname ehsl_novel_nam
Date Created 2020-04-21
Date Modified 2020-05-27
ID 1542114
Reference URL
Back to Search Results